banner
New Risk Analysis
Welcome.  Sign in or register.
Refer A Friend | Contact Us
Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1053 U.S. listed China Stocks and Counting...
 Tracking 1535 U.S. Stocks and Counting...
Home
Market Activity
Shell Activity
Research
Message Boards
GeoBlog
About
GeoResearchGeoBargainsGeoSpecialsGuidanceMake GoodsPenny StocksRecent AdditionsAll Companies

 Jiangbo Pharmaceuticals Enterprises, Inc. (PINK:JGBO)

GeoProfile
    Overview
GeoResearch
Message Board
Alerts Log
GeoWire Log  
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders
Monday, September 26, 2011, 12:00 AM
Documents shed light on pitfalls of China audits.
WASHINGTON, Sept 26 (Reuters) - When Michael Marks and John Wang stepped off the board of directors of Jiangbo Pharmaceuticals JGBO.O in June, they said goodbye to the Chinese company with a 23-page resignation letter complaining of months…

Home  |   Market Activity  |   Research  |   Message Boards  |   My Account  |   Refer a Friend   |   Contact Us

About  |   Site Map  |   Privacy Policy  |   Terms of Service  |   Twitter  |   © 2009 GeoInvesting LLC


Articles | Asian Stock | Asian Stock Market | Asian Stocks | Business Outlook | Company Analysis | Company Profile
Day Trading | Stock Analysis| Stock Research


Statements and scenarios on GeoInvesting are not intended to be investment advice, but are based on some
commonly used investment guidelines. They are provided to aid investors in making their own investment decisions.
Please review GeoInvesting's complete disclosures and disclaimers under the link above regarding "Terms of Service."